Close Menu

product launch

The UK firm which went public last month has developed an instrument about the size of a PC targeting laboratories, both small and large, that may not have the space for a conventional platform.

The real-time, single-molecule sequencing technology firm reported $270,000 in grant revenue for the quarter. Its CEO said during a conference call that the company has an order backlog of 44 PacBio RS systems.

Researchers participating in the Allen Institute for Brain Science's Human Brain Atlas project announced that they have generated gene expression and other data at 1,000 anatomical sites each for two human brains.

With the launch of the Ion Torrent platform, Life Technologies said that it will award $1 million each to winners who can use the technology to improve upon results achieved internally in the first phase of the Life Grand Challenges Contest.

The firm is nearing a market launch of the system, called the nanoAnalyzer 1000. The system is being developed for a variety of applications including genome assembly, structural variation analysis, and assessing DNA damage.

Building off data presented today at the International Thyroid Congress, the molecular diagnostics firm is moving ahead to launch its tests later this year that it says would reduce the amount of unnecessary thyroidectomies.

The company's first test, a FISH-based assay targeting breast cancer, is planned for October and would represent its first product introduction in its 13-year history.

The new, low-throughput instrument was launched today, and EMD Millipore was named as a global distributor.


The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.